Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 40Anemia, Refractory, with Excess of Blasts 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Leukemia, Lymphocytic, Chronic, B-Cell 28Myelodysplastic Syndromes 27Lymphoma, Non-Hodgkin 27Leukemia, Myelomonocytic, Chronic 27Hodgkin Disease 27Multiple Myeloma 24Primary Myelofibrosis 21Myeloproliferative Disorders 21Lymphoma, Follicular 21Leukemia 21Lymphoma 20Lymphoma, Mantle-Cell 19Congenital Abnormalities 19Leukemia, Myeloid, Chronic-Phase 18Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Anemia, Refractory 18Lymphoma, B-Cell, Marginal Zone 17Burkitt Lymphoma 17Lymphoma, Large B-Cell, Diffuse 16Lymphoma, Large-Cell, Immunoblastic 15Leukemia, Myeloid, Accelerated Phase 15Dendritic Cell Sarcoma, Interdigitating 13Neoplasms, Plasma Cell 12Recurrence 11Blast Crisis 11Anemia, Aplastic 11Leukemia, Myelomonocytic, Juvenile 10

Interventions

Melphalan 3Cyclophosphamide 3thymoglobulin 2fludarabine 2Whole-Body Irradiation 2Rituximab 2Mycophenolic Acid 2Busulfan 2fludarabine phosphate 1Tacrolimus 1Sirolimus 1Levetiracetam 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cord Blood Stem Cell Transplantation 1Clofarabine 1CT-P10 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasm, Residual × Mycophenolic Acid × Classical hematology × Clear all
NCT03192397 2026-04-14

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Roswell Park Cancer Institute

Phase 1/2 Active not recruiting
35 enrolled 19 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Neoplasm, Residual

NCT03096782 2023-10-11

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
6 enrolled 10 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡